- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Shukra Pharmaceuticals' board has approved the financial results for the quarter ended June 30, 2025. The company reported a robust operational performance with revenue from operations reaching Rs. 5.39 Cr, a significant increase from Rs. 3.18 Cr in the same quarter last year. Net profit for the period stood at Rs. 1.03 Cr, up from Rs. 0.49 Cr year-over-year. The Board also reviewed the company's overall business. This update provides key insights into the company's recent financial health and growth trajectory for stakeholders.